Web Results

en.wikipedia.org/wiki/Trastuzumab

Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer. Specifically it is used for breast cancer ...

www.herceptin.com

Find information about Herceptin® (trastuzumab), a targeted therapy for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer. Indications  ...

chemocare.com/chemotherapy/drug-info/Trastuzumab.aspx

Trastuzumab (Herceptin) monoclonal antibody therapy side effects, how it's given , how it works, precautions and self care tips for treatment of breast and gastric ...

ww5.komen.org/BreastCancer/Trastuzumab.html

Studies show for women with HER2-positive early breast cancer, chemotherapy plus trastuzumab cuts the risk of recurrence in half compared to chemotherapy ...

www.cancer.gov/about-cancer/treatment/drugs/trastuzumab

Oct 5, 2006 ... This page contains brief information about trastuzumab and a collection of links to more information about the use of this drug, research results, ...

www.cancer.gov/about-cancer/treatment/drugs/fda-trastuzumab

Jul 3, 2013 ... On October 20, 2010, the Food and Drug Administration (FDA) granted approval for trastuzumab (Herceptin®, made by Genentech, Inc.), ...

www.rxlist.com/herceptin-drug.htm

Learn about Herceptin (Trastuzumab) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications.

www.nejm.org/doi/full/10.1056/NEJMe058196

Oct 20, 2005 ... Two articles in this issue of the Journal report on the considerable therapeutic benefit of trastuzumab, a monoclonal antibody, in primary breast ...

www.nejm.org/doi/full/10.1056/NEJMra043186

Jul 5, 2007 ... Review Article from The New England Journal of Medicine — Trastuzumab — Mechanism of Action and Use in Clinical Practice.

www.gene.com/patients/medicines/herceptin

Find important safety information and patient resources for all of our currently marketed medicines.